Inhalation antibacterial drugs: current opportunities for use in respiratory infections

Autor:	S. K. Zyryanov, O. I. Butranova
Rok vydání:	2020
Předmět:	Pulmonary and Respiratory Medicine animal structures Inhalation Resistance development Antibacterial therapy business.industry fungi Medicine Pharmacology business Antibacterial Drug Resistance Thiamphenicol glycinate acetylcysteinate
Zdroj:	Russian Pulmonology. 30:320-328
ISSN:	2541-9617 0869-0189
DOI:	10.18093/0869-0189-2020-30-3-320-328
Popis:	The need to find ways to improve the effectiveness of antibacterial therapy is due to the dramatic escalation of resistance to antibacterial drugs (ABD), with the growth rate of resistance of ABD microorganisms ahead of the new drugs development. According to available data, the pathway of ABD administration may correlate with the phenomenon of resistance development to ABD. Actual data on existing inhalation ABDs, allowing to estimate their efficiency and safety, are considered in the article. In the treatment of patients with infectious respiratory diseases, an alternative to the systemic use of ABD may be inhalation administration of a number of ABDs, whose activity depends on concentration.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::34bd6f8042154c320da0df30472ae4e1 https://doi.org/10.18093/0869-0189-2020-30-3-320-328 Zobrazit plný text záznamu